These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21466244)

  • 1. Impact of pregabalin treatment on pain, pain-related sleep interference and general well-being in patients with neuropathic pain: a non-interventional, multicentre, post-marketing study.
    Anastassiou E; Iatrou CA; Vlaikidis N; Vafiadou M; Stamatiou G; Plesia E; Lyras L; Vadalouca A;
    Clin Drug Investig; 2011; 31(6):417-26. PubMed ID: 21466244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.
    van Seventer R; Feister HA; Young JP; Stoker M; Versavel M; Rigaudy L
    Curr Med Res Opin; 2006 Feb; 22(2):375-84. PubMed ID: 16466610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
    Baron R; Brunnmüller U; Brasser M; May M; Binder A
    Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
    Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of pregabalin in patients with central post-stroke pain.
    Kim JS; Bashford G; Murphy KT; Martin A; Dror V; Cheung R
    Pain; 2011 May; 152(5):1018-1023. PubMed ID: 21316855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.
    Dauri M; Lazzari M; Casali M; Tufaro G; Sabato E; Sabato AF
    Clin Drug Investig; 2014 May; 34(5):309-16. PubMed ID: 24567278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.
    Cardenas DD; Emir B; Parsons B
    Clin Ther; 2015 May; 37(5):1081-90. PubMed ID: 25850879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies.
    Semel D; Murphy TK; Zlateva G; Cheung R; Emir B
    BMC Fam Pract; 2010 Nov; 11():85. PubMed ID: 21054853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
    Saldaña MT; Pérez C; Navarro A; Masramón X; Rejas J
    Clin Drug Investig; 2012 Jun; 32(6):401-12. PubMed ID: 22480279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial.
    van Seventer R; Bach FW; Toth CC; Serpell M; Temple J; Murphy TK; Nimour M
    Eur J Neurol; 2010 Aug; 17(8):1082-9. PubMed ID: 20236172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
    Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
    Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
    Cardenas DD; Nieshoff EC; Suda K; Goto S; Sanin L; Kaneko T; Sporn J; Parsons B; Soulsby M; Yang R; Whalen E; Scavone JM; Suzuki MM; Knapp LE
    Neurology; 2013 Feb; 80(6):533-9. PubMed ID: 23345639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.
    Lampl C; Schweiger C; Haider B; Lechner A
    J Neurol; 2010 Aug; 257(8):1265-73. PubMed ID: 20221770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.